[Comparative characteristics of immunomodulators in the combined treatment of patients with mandibular fractures].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D003131:Combined Modality Therapy; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005593:Fracture Fixation, Internal; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D008337:Mandibular Fractures / Q000276:immunology / Q000628:therapy*; D013450:Sulfones / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000517:prevention & control; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013997:Time Factors; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D013450:Sulfones; D007978:Levamisole; C023367:diucifon; D014498:Uracil
Sravnitel'naia kharakteristika primeneniia immunomoduliatorov v kompleksnom lechenii bol'nykh s perelomami nizhneĭ cheliusti.